Blood based proteomic biomarkers of Alzheimer’s disease pathology
The complexity of Alzheimer’s disease (AD) and its long prodromal phase poses challenges for early diagnosis and yet allows for the possibility of the development of disease modifying treatments for secondary prevention. It is therefore of importance to develop biomarkers, in particular in the precl...
Main Authors: | Alison Louise Baird, Sarah eWestwood, Simon eLovestone |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-11-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00236/full |
Similar Items
-
The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
by: Sarah Westwood, et al.
Published: (2017-04-01) -
Blood-based biomarkers in Alzheimer’s disease: an overview on proteomic and lipidomic approaches
by: Ilinoiu Geanina Andreea, et al.
Published: (2016-06-01) -
The potential of pathological protein fragmentation in blood-based biomarker development for dementia – with emphasis on Alzheimer’s disease
by: Dilek eInekci, et al.
Published: (2015-05-01) -
Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
by: Bing Bai, et al.
Published: (2021-08-01) -
Biomarkers in Alzheimer’s Disease Analysis by Mass Spectrometry-Based Proteomics
by: Yahui Liu, et al.
Published: (2014-05-01)